The phosphorylation of heterochromatin protein 1 (HP1) has been previously described in studies of mammals, but the biological implications of this modification remain largely elusive. Here, we show that the N-terminal phosphorylation of HP1␣ plays a central role in its targeting to chromatin. Recombinant HP1␣ prepared from mammalian cultured cells exhibited a stronger binding affinity for K9-methylated histone H3 (H3K9me) than that produced in Escherichia coli. Biochemical analyses revealed that HP1␣ was multiply phosphorylated at N-terminal serine residues (S11-14) in human and mouse cells and that this phosphorylation enhanced HP1␣'s affinity for H3K9me. Importantly, the N-terminal phosphorylation appeared to facilitate the initial binding of HP1␣ to H3K9me by mediating the interaction between HP1␣ and a part of the H3 tail that was distinct from the methylated K9. Unphosphorylatable mutant HP1␣ exhibited severe heterochromatin localization defects in vivo, and its prolonged expression led to increased chromosomal instability. Our results suggest that HP1␣'s N-terminal phosphorylation is essential for its proper targeting to heterochromatin and that its binding to the methylated histone tail is achieved by the cooperative action of the chromodomain and neighboring posttranslational modifications.
The phosphorylation of heterochromatin protein 1 (HP1) has been previously described in studies of mammals, but the biological implications of this modification remain largely elusive. Here, we show that the N-terminal phosphorylation of HP1␣ plays a central role in its targeting to chromatin. Recombinant HP1␣ prepared from mammalian cultured cells exhibited a stronger binding affinity for K9-methylated histone H3 (H3K9me) than that produced in Escherichia coli. Biochemical analyses revealed that HP1␣ was multiply phosphorylated at N-terminal serine residues (S11-14) in human and mouse cells and that this phosphorylation enhanced HP1␣'s affinity for H3K9me. Importantly, the N-terminal phosphorylation appeared to facilitate the initial binding of HP1␣ to H3K9me by mediating the interaction between HP1␣ and a part of the H3 tail that was distinct from the methylated K9. Unphosphorylatable mutant HP1␣ exhibited severe heterochromatin localization defects in vivo, and its prolonged expression led to increased chromosomal instability.
Our results suggest that HP1␣'s N-terminal phosphorylation is essential for its proper targeting to heterochromatin and that its binding to the methylated histone tail is achieved by the cooperative action of the chromodomain and neighboring posttranslational modifications.
The formation of the higher-order chromatin structure, the so-called heterochromatin, is critical for genomic stability and transcriptional silencing (19, 21, 30) . Heterochromatin protein 1 (HP1) is a nonhistone chromosomal protein that was initially discovered in Drosophila melanogaster as a factor that is enriched at highly condensed, transcriptionally inert regions of polytene chromosomes (24, 25) . HP1 is an evolutionarily conserved molecule whose homologues and isoforms have been previously identified in a wide range of eukaryotic organisms (9) . As well as being an architectural component of heterochromatin, HP1 is known to play crucial roles in heterochromatin-mediated gene silencing. Profound effects of HP1 deletion, mutation, or overexpression on transcriptional silencing have been previously demonstrated in Drosophila (11, 12) , Schizosaccharomyces pombe (13) , and mammals (17) . Moreover, an ever-expanding list of HP1-interacting proteins indicates that HP1 may also be involved in the regulation of several biological processes, including transcriptional activation, faithful chromosome segregation, and DNA damage repair (8, 19, 21, 30) .
Structurally, all HP1 homologues possess two functionally distinct globular domains, the N-terminal chromodomain (CD) (39) and the C-terminal chromoshadow domain (CSD) (1) , which are linked by an unstructured hinge region. The CD recognizes and interacts with methylated lysine 9 of the histone H3 N-terminal tail, which is a characteristic modification in heterochromatic regions (4, 27, 35) . The CSD, on the other hand, is responsible for dimer formation and is involved in HP1's interactions with a large variety of proteins (5, 44, 46) . Because of its abilities to bind directly to chromatin and to form dimers and oligomers, HP1 is thought to contribute to the formation and/or stabilization of higher-order chromatin structure by cross-linking methyl H3K9-marked nucleosomes (4) .
In contrast to the cytological appearance of heterochromatin, the interaction between HP1 and chromatin is not static but highly dynamic (6, 16) . The kinetics of the interaction can change according to cellular circumstances; for example, alterations in the kinetics of the HP1-chromatin interaction were previously demonstrated during T-lymphocyte activation (16) and embryonic stem (ES) cell differentiation (33) . Several mechanisms for these changes in HP1-chromatin interaction kinetics have been proposed. For example, alterations in the histone modifications or in the levels of other HP1-interacting partners appear to change the HP1-chromatin interaction (18, 22, 33) . Alternatively, posttranslational modification of the HP1 protein itself may modulate HP1's dynamics and functions. Drosophila studies have revealed that HP1 is highly phosphorylated in vivo (10) and that phosphorylation of HP1 influences its heterochromatin binding and silencing activity (47, 48) , although elucidation of the underlying molecular mechanisms remains elusive.
There is accumulating evidence that mammalian HP1 homologues are also highly phosphorylated (28, 34, 38) , suggesting that the mammalian HP1 function is also regulated by phosphorylation. For instance, HP1␥ Ser-83 phosphorylation impairs HP1␥'s silencing activity and serves as a marker for transcriptional elongation (29) . In addition, HP1␤ Ser-51 phosphorylation has previously been linked to HP1␤ mobilization during the initiation of the DNA damage response (3). Nevertheless, the biological functions of the HP1 phosphorylation in mammals remain largely unclear.
In this study, we show that mammalian HP1␣ is phosphorylated at its N-terminal serine residues and that this phosphorylation plays a critical role in modulating HP1␣'s activity to efficiently bind to the methylated histone H3 tail. Interestingly, the N-terminal phosphorylation appears to persist during the cell cycle and form an essential structural unit of HP1␣ to ensure its chromatin binding. and 10 mM sodium fluoride (NaF). For dephosphorylation, an aliquot of wholecell lysate (WCL) was incubated with 0.08 U/ml shrimp alkaline phosphatase (SAP) (TaKaRa) for 3 to 6 h at 37°C. Western blotting was performed according to a standard protocol. Alternatively, the blocking and antibody treatments were carried out using the SNAP identification system (Millipore). The intensity of each protein band was quantified using NIH ImageJ software, and the relative levels of Western blotting signals are presented in the figures. For polyacrylamide gel electrophoresis using a chemical reagent called Phos-tag (26) (here, we refer to SDS-PAGE analysis using this reagent as "phos-tag-PAGE"), 50 or 80 M phos-tag-acrylamide (Wako) and an equal volume of 10 mM MnCl 2 were added to a 10% (for full-length domains) or 12% (for CD) SDS-PAGE gel. Prior to the transfer of proteins, the phos-tag gels were incubated with transfer buffer containing 5 mM EDTA for 20 min and subsequently washed with fresh transfer buffer for 15 min.
Peptide pulldown assays. Peptides were synthesized by Sigma Genosys. The peptides used in this study were unmodified H3 (H3unmod [ ARTKQTARKS TGGKAPRKQL-C]), K9-trimethylated H3 (H3K9me3 [ARTKQTARKme 3 ST GGKAPRKQL-C]), unmodified mutant H3 (ARTKQTARKme 3 STGGQAPRQ QL-C), and K9-trimethylated mutant H3 [ARTKQTARKme 3 STGG(A/Q)APR (A/Q)QL-C]. Peptides (50 nmol) were covalently linked to 500 l (bed volume) of Sulfo-link Sepharose resin (Pierce) via an artificially added C-terminal cysteine residue (peptide beads). Then, 1 pmol of recombinant HP1 was incubated with 10 l (bed volume) of the peptide beads (protein:peptide ϳ 1:1,000) in 150 l of binding buffer (20 mM Tris-Cl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 0.1% Triton X) for 1 h at room temperature (RT). The beads were then washed twice with 500 l of binding buffer. The bound proteins were eluted by mixing the beads with 45 l of SDS sample buffer and boiling. Equal volumes of input, unbound, and bound fractions were analyzed by immunoblotting using antibodies against each HP1 isoform. Since input and unbound fractions (150 l) were mixed with 30 l of 6ϫ SDS sample buffer, the isovolume-bound fraction corresponded to 4ϫ the input. For quantitative pulldown assays, 1 pmol of protein was incubated with a 500-, 1,000-, 5,000-, or 10,000-fold molar excess of peptide beads. For the elution analysis, four aliquots of 1 pmol of recombinant protein were first bound to 10 l of H3K9me3 beads as described above. Following the washes, the beads were then incubated in 150 l of binding buffer containing a 0-, 100-, 1,000-, or 10,000-fold molar excess of free H3K9me3 peptides for 1 h. The beads were washed twice with 500 l of binding buffer, and the bound proteins were eluted and analyzed.
Immunopurification of 6؋His-and FLAG-tagged HP1 from NIH 3T3 cells. NIH 3T3-expressed 6ϫHis-HP1␣, -HP1␤, and -HP1␥ were purified using a different procedure from that used for the bacterially expressed counterpart. NIH 3T3 cells expressing 6ϫHis-HP1 were lysed in NP-40 lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% NP-40) supplemented with protease inhibitor cocktail (Complete [EDTA-free]; Roche) and 50 mM NaF and were subjected to sonication (5 pulses at 30% amplitude) on ice. 6ϫHis-HP1 was purified using a His-tagged protein purification kit (MBL) according to the manufacturer's instructions. The protein concentration was estimated by comparing the intensity of silver-or CBB (Coomassie)-stained protein bands with that of bands corresponding to bacterially produced HP1 of a known concentration. For FLAG-tagged HP1, the cells were resuspended in IP lysis buffer (50 mM HEPES [pH 7.9], 10% glycerol, 250 mM NaCl, 0.1% Triton X) supplemented with protease inhibitor cocktail and 50 mM NaF and were further lysed by three freeze-thaw cycles. FLAG-tagged HP1 was purified with anti-FLAG M2 affinity gel and eluted by adding 1ϫ FLAG peptide (Sigma).
MS. Immunoaffinity-purified 6ϫHis-or FLAG-tagged HP1␣ was concentrated using a Microcon system (Millipore), dialyzed against phosphate-buffered saline (PBS), and resolved by 15% SDS-PAGE. After Coomassie staining, the corresponding band was excised from the gel and subjected to in-gel reduction with 10 mM DTT, alkylation with 55 mM iodoacetamide, and digestion with 10 ng/l modified trypsin (Promega) at 37°C for 16 h. After in-gel digestion, the phosphorylated peptides were concentrated using a Titansphere Phos-Tio kit (GL Science Inc.). The collected phosphorylated peptides were subjected to mass spectrometry (MS) analysis as described previously (41) . For phosphorylated peptides, the ion trap was programmed to carry out four successive scans con-VOL. 31 ) and K9-trimethylated H3 (fluorescein-C-[GARTKQTARKme3STGGKAY]) were synthesized, and the yields were determined by absorption spectroscopy at A 280, using the absorbance of an artificially added C-terminal tyrosine residue. The fluorescence intensity of fluorescein in FP buffer (50 mM potassium phosphate [pH 7.0], 25 mM NaCl, 1 mM DTT) at 30°C was observed using an FP-6500 fluorescence spectrometer (JASCO) or an F2700 fluorescence spectrophotometer (Hitachi High-tech). The temperature was controlled by circulating water around a water-jacketed cell holder. Linear polarization filters (HN32 from Polaroid Co.) were inserted in both the excitation and emission light paths, and their orientations were manually controlled in each set of measurements to calculate the anisotropy values. The excitation and emission wavelengths were 420 and 520 nm, respectively. The fluorescein-labeled peptide (10 nM) was incubated with increasing concentrations of recombinant HP1CD. The fluorescence anisotropy values (R) were plotted against the protein concentrations. Curve-fitting analyses and K d (dissociation constant) estimations were carried out using IGOR Pro software (version 6.05A; WaveMatrics). The observed data fit very well into the equations (assuming a 1:1 binding stoichiometry ratio) as shown below:
where PL, L 0 , and P 0 represent the equilibrium concentration of the proteinligand complex, the total ligand-peptide concentration (constant), and the total protein concentration, respectively. R represents the fluorescence anisotropy at a certain protein concentration. R c and R d represent the reference fluorescence anisotropy values seen when 100% of the fluorescent peptide molecules are complexed with protein molecules and when no protein is present (i.e., there is no peptide-protein complex) in the reaction, respectively.
Immunofluorescence microscopy. Cells grown on coverslip-bottomed culture dishes (MatTek) were washed briefly with phosphate-buffered saline (PBS) and fixed with 3.7% formaldehyde for 10 min at RT. The fixed cells were permeabilized with 0.5% Triton X-PBS for 5 min at RT and blocked with 2.5% bovine serum albumin (BSA) in PBS for 30 min at RT. The cells were then incubated with an anti-phosphohistone H3 antibody (1/500 in blocking buffer with 0.05% Tween 20) for 2 h and subsequently with Cy3-conjugated anti-rabbit IgG (1/500 in blocking buffer with 0.05% Tween 20) for 1 h at RT. After each staining step, the cells were washed three times with PBST (PBS containing 0.05% Tween 20) . The cells were counterstained with DAPI (4Ј,6-diamidino-2-phenylindole) (1 mg/ml)-PBST and mounted in antifade reagent (Invitrogen). Pictures were acquired with an Olympus microscope and analyzed using MetaMorph software (Universal Imaging), NIH ImageJ software, or DeltaVision softWoRx software (Applied Precisions). For categorization of EGFP-HP1␣ localization, the brightest EGFP spot in the nucleus was chosen, and the fluorescent intensity (FI) of the EGFP at that spot and the FI of background (euchromatic) area were measured with a line-plotting tool. In cases in which there was no clear EGFP spot, the most DAPI-dense area was analyzed. The FI ratio of the brightest EGFP-HP1␣ spot and background region was calculated, and the EGFP-HP1␣ localization patterns were categorized as follows: strong (FI ratio Ն 1.8), weak (1.8 Ͼ FI ratio Ͼ 1), or diffused (1 Ն FI ratio). The cutoff ratio was set at 1.8 because over 80% of the cells expressing wild-type EGFP-HP1␣ (EGFP-HP1␣WT) consistently gave a ratio equal to or higher than 1.8.
Chromatin fractionation assay. The chromatin fractionation was carried out essentially as described previously (46) . NIH 3T3 cells stably expressing FLAGtagged HP1␣WT or mutant HP1␣S14A were transfected with 100 pmol of control siRNA (small interfering RNA) (siTrio negative control; B-Bridge International) or siRNA against the HP1␣ 3Ј untranslated region (UTR) (siHP1␣ [sense, 5Ј-ggaucagucugagaguuaTT-3Ј; antisense, 5Ј-uaacucucagacuguauccTT-3Ј; uppercase represents artificially added 3Ј overhangs]) (B-Bridge International) by the use of a 12-well plate and Lipofectamine RNAiMAX (Invitrogen). After 48 h, the siRNA-treated cells were washed twice with PBS and incubated in PBS with 0.1% Triton X for 10 min at 4°C. The soluble fraction was collected by centrifugation at 2,000 rpm (390 ϫ g) for 2 min. The remaining pellet was washed once with PBS and lysed in SDS-sample buffer.
Establishment of stable NIH 3T3 cell clones. FLAG-HP1␣ (WT or S11-14A)-expressing plasmid (pCAGI/puromycin) was linearized by FspI digestion and introduced into NIH 3T3 cells by the use of Lipofectamine LTX and Plus reagent (Invitrogen). After 48 h, the cells were diluted and subcultured, and stably transfected cells were selected by treatment with 3 g/ml puromycin for 72 h. Puromycin-resistant clones were isolated and subcultured in a culture medium without antibiotics. Expression of FLAG-HP1␣ was checked by Western blotting and immunofluorescence analysis using anti-HP1␣ and anti-FLAG antibodies, respectively.
Coimmunoprecipitation of native nucleosomes with FLAG-HP1␣. ⌵⌱⌯ 3T3 cells stably expressing FLAG-HP1␣WT or S11-14A were lysed in 600 l of IP lysis buffer containing 5% glycerol with brief sonication. To solubilize nucleosomes and chromatin-bound proteins, lysates were supplemented with 0.6 l of 1 M CaCl 2 and treated with 120 U of micrococcal nuclease (TaKaRa) for 30 min at room temperature. Nuclease digestion was quenched by the addition of 6 l of 0.5 M EDTA. The lysates were precleared with Sepharose 4B (GE Healthcare) and then incubated with anti-FLAG M2 affinity gel. The beads were extensively washed with IP lysis buffer, and FLAG-HP1␣ complexes were eluted by adding 1ϫ FLAG peptide (Sigma). The eluates were analyzed by Western blotting using anti-histone H3 antibodies.
Preparation of chromosome spreads. Cells were treated with 50 ng/ml demecolcine (Sigma) for 1 h, and single-cell suspensions were prepared by trypsin treatment. The cells were swelled by treatment with 7 ml of 75 mM KCl for 10 min at 37°C, mildly prefixed by adding 0.8 ml of fixative (methanol:acetic acid ϭ 3:1), and collected by centrifugation at 800 rpm (120 ϫ g) for 3 min. The cells were then fixed by the addition of ice-cold fixative. The fixed cells were spotted onto a glass slide, dried in air, and rinsed with 70% acetic acid. The cells were then stained with DAPI, mounted in Slowfade reagent (Invitrogen), and observed under a fluorescence microscope using a UPlanSApo lens (Olympus) (100ϫ objective).
RESULTS
Bacterially produced HP1␣ shows poor binding to the K9-methylated histone H3 tail. Mammalian cells express three HP1 isoforms, HP1␣ (Cbx5), HP1␤ (Cbx1), and HP1␥ (Cbx3). These proteins are thought to target chromatin via an interaction between the chromodomain (CD) and K9-trimethylated histone H3 (H3K9me3), but the molecular basis of their distinct localization and cellular functions remains largely unknown. To investigate the chromatin-targeting mechanisms of these isoforms, we produced recombinant mouse HP1␣, -␤, and -␥ by the use of E. coli cells (Fig. 1A) and examined their ability to interact with H3K9me3 in a peptide pulldown assay using peptide-cross-linked beads (Fig. 1B) .
Both recombinant HP1␤ and HP1␥ strongly bound to the H3K9me3 peptide and showed only negligible binding to unmodified H3 peptide. HP1␣ also bound to H3K9me3, but its binding ability was clearly weaker than that of HP1␤ or HP1␥, as evidenced by the larger unbound (U) fraction (Fig. 1B) . While a similar result indicating that HP1␣CD shows weaker binding to H3K9me3 than HP1␤CD or HP1␥CD was previously reported (18), these results seemingly contradict the observation that mammalian HP1␣ shows a clear heterochromatic localization (34) . To further examine the interaction between HP1␣ and H3K9me3, we produced HP1␣ in NIH 3T3 cells and subjected it to affinity purification for pulldown assays (Fig. 1C) . Interestingly, the HP1␣ prepared from NIH 3T3 cells bound to the H3K9me3 more strongly than that produced from E. coli (Fig. 1D) , with a binding affinity comparable to that of recombinant HP1␤ and HP1␥ (compare Fig.  1B and 1D ). This phenomenon was specific to HP1␣; no clear difference in levels of affinity was observed between E. coli-and NIH 3T3-expressed proteins for HP1␤ and HP1␥ (data not shown). In addition, the HP1␣ prepared from NIH 3T3 cells migrated more slowly in an SDS-PAGE gel than the E. coliexpressed HP1␣ (Fig. 1C) , although both contained the same peptide sequence. Together, these results suggested that some kind of posttranslational modification(s) of HP1␣ modulates its binding to H3K9me3.
Mouse HP1␣ exhibits two distinct types of phosphorylation. The difference in the apparent molecular sizes of E. coliversus NIH 3T3-produced HP1␣ was only several kilodaltons (Fig. 1C) , and phosphorylation is a candidate for such posttranslational modifications. When endogenous HP1␣ was treated with shrimp alkaline phosphatase (SAP), a similar band shift in the SDS-PAGE gel was observed ( Fig. 2A, mock) , suggesting the involvement of phosphorylation in the recombinant HP1␣ migration change. Recent proteomics studies identified phosphorylation sites of human HP1␣ (28, 38) , but the relative abundances, dynamics, and physiological roles of these phosphorylations remained unclear. Therefore, we investigated the HP1␣ phosphorylation patterns by the use of mouse NIH 3T3 cells.
To examine HP1␣ phosphorylation in detail, we used Phostag (26) . In the presence of manganese(II) ion (Mn 2ϩ ), Phostag forms a complex with two Mn 2ϩ ions and selectively traps R-OPO 3 2Ϫ (R ϭ protein, peptide, DNA, etc.). Therefore, the addition of this chemical to a PAGE gel slows down the migration of phosphorylated proteins in SDS-PAGE. The degree of the band shift depends on the number of phosphate groups on a single protein molecule and the site of phosphorylation within a protein. The endogenous HP1␣ in NIH 3T3 cells was detected as at least two distinct bands by the use of phos-tag-PAGE, and both bands shifted to a faster-migrating form after SAP treatment ( Fig. 2A, phos-tag) , indicating that the majority of the HP1␣ was phosphorylated at one or more sites.
We next examined whether the phosphorylation pattern of HP1␣ changes according to cell cycle stage. NIH 3T3 cells were grown under asynchronous (control), serum-starved (G 0 -arrest), or nocodazole-treated (G 2 /M-arrest) conditions. G 2 / M-arrested cells were further enriched by the mitotic shake-off method, and then the phosphorylation state of HP1␣ in these cells was analyzed by phos-tag-PAGE (Fig. 2B ). HP1␣ showed a major band that was consistently present irrespective of the cell cycle stage in all the cell populations (Fig. 2B, arrowhead) , and slower-migrating minor bands appeared with different degrees of intensity, depending on the cell cycle stage (Fig. 2B,  asterisk) . All the HP1␣ species shifted to the faster-migrating form after SAP treatment (Fig. 2B, ϩSAP) . Since the unphosphorylated form of HP1␣ was hardly detected in the examined cell cycle stages, it appeared that HP1␣ was constitutively phosphorylated at one or more sites in vivo. The intensities and numbers of slower-migrating bands were relatively low in G 0 -phase-arrested and asynchronous cells but became prominent in the G 2 /M-phase-arrested cells, indicating that these bands represented "metaphase-associated" phosphorylation. These results agree with a previous observation from a study of human cells showing HP1␣ to be more heavily labeled with radioactive phosphate in G 2 /M-phase-arrested cells than in asynchronous cells (34) . Determination of the phosphorylation sites of mouse HP1␣. To determine the phosphorylation sites of HP1␣, we cloned mouse HP1␣ cDNA and introduced amino acid substitutions for the candidate serine residues that were predicted by several phosphorylation site prediction programs (Fig. 2C , indicated in boldface; see also Materials and Methods). The wild-type (WT) or mutant HP1␣ was expressed with the FLAG tag in NIH 3T3 cells, and the phosphorylation patterns found under asynchronous conditions were examined by phos-tag-PAGE. Wild-type HP1␣ (HP1␣WT) was detected as two distinct bands, both of which shifted to a faster-migrating band after SAP treatment (Fig. 2D, WT) . The overall band patterns and relative migration levels were similar to those of endogenous HP1␣ ( Fig. 2A) .
Amino acid substitutions in the N-terminal region altered the migration levels of both the faster-and slower-migrating bands (Fig. 2D, N-term) . On the other hand, mutations in the hinge region led to the specific disappearance of the slowermigrating band (Fig. 2D, Hinge) . Combining both mutations resulted in a shift of all the species to the unphosphorylated level (Fig. 2D, N-term ϩ hinge) . These results suggest that the faster-migrating HP1␣ contains phosphorylated serine residues in its N terminus, whereas the slower-migrating HP1␣ contains the metaphase-associated phosphorylation in its hinge region in addition to the N-terminal phosphorylation.
To further characterize the phosphorylation sites, we created HP1␣ mutants carrying a single point mutation in the N-terminal (S11A, S12A, S13A, or S14A) or hinge (S92A, S93A, S95A, or S97A) region. Three N-terminal point mutations, S11A, S12A, and S13A, only slightly changed the overall migration pattern of HP1␣ (Fig. 2E, asterisks) . In contrast, the S14A mutation caused a dramatic shift of the band, reaching the level of the unphosphorylated control (Fig. 2E [S14A, arrowheads]) and indicating that S14 is the key N-terminal phosphorylation site. Although the presence of phosphorylation at S11, S12, or S13 has not been clearly demonstrated by the mutation studies, mass spectrometry analysis of affinitypurified HP1␣ enabled us to identify peptides containing phosphorylation(s) at these residues in addition to S14 phosphorylation ( Fig. 2G and data not shown) . Together, these results suggested that the N-terminal serine residues (S11-S14) are multiply phosphorylated in vivo and that S14 phosphorylation is a prerequisite for or enhances the phosphorylation of its neighboring serine residues.
With regard to the hinge phosphorylation, the S93A mutation caused the loss of the slower-migrating HP1␣ (Fig. 2F) , suggesting that S93 is the major metaphase-associated phosphorylation site. In addition to S93, S95 and S97 may play a role in the control of HP1␣'s phosphorylation in vivo, since there were slight but obvious shifts in the bands of the S95A and S97A mutants compared with WT results (Fig. 2F ) and phosphorylation at those serine residues was detected by mass spectrometry analysis (Fig. 2G) . Taken together, the results indicated that N-terminal phosphorylation contributes to the major band shift of HP1␣ whereas S93 in the hinge region is the major mitotic phosphorylation site in vivo (Fig. 2H) .
The N-terminal phosphorylation of HP1␣ enhances its binding to H3K9me3. The N-terminal phosphorylation for the HP1␣ in different mouse and human cells was widely observed (Fig. 3A) . In addition, the corresponding serine residues lie close to the conserved CD (Fig. 3B) . We therefore hypothesized that the N-terminal phosphorylation could affect the interaction between the CD and H3K9me3. To test this directly, we introduced N-terminal phosphorylation in vitro and examined the binding affinity of the phosphorylated HP1␣ for H3K9me3.
Since the N-terminal serine residues closely resemble the consensus target sequence of casein kinase II (CK2) (Fig. 3B ) (40), we first examined whether the N-terminal serine residues of HP1␣ could be phosphorylated by CK2 in vitro (see Materials and Methods). The incubation of recombinant HP1␣ (HP1␣WT) with CK2 led to a clear band shift, and two distinct bands (major and minor) were detected using phos-tag-PAGE (Fig. 3C , WT and CK2ϩ). The shift of the major band was completely abolished when the S11-14A mutation was introduced into the recombinant HP1␣ (Fig. 3C, S11-14A ), showing that the N-terminal serine residues of HP1␣ were phosphorylated by CK2 in vitro. The presence of the CK2-mediated . Serine residues that could be phosphorylated are underlined, and the surrounding acidic amino acid residues are shown in red. (C) In vitro kinase activity of CK2 for the recombinant HP1␣. 6ϫHis-tagged HP1␣WT, HP1␣S14A, and HP1␣S11-14A were treated with recombinant CK2, and the phosphorylation states were analyzed by phos-tag SDS-PAGE, followed by Coomassie staining. (D) LC-MS/MS analysis of CK2-treated full-length HP1␣ (HP1␣FL) and HP1␣ chromodomain (HP1␣CD). (E) In vitro pulldown assays with N-terminally phosphorylated HP1␣. Bacterially produced 6ϫHis-HP1␣ (WT and S11-14A) was phosphorylated using recombinant CK2 in vitro. The CK2-phosphorylated-and control HP1␣s were subjected to pulldown assays with the H3unmod. and H3K9me3 peptides as described for Fig. 1B. (F) Binding of the HP1-CD to fluorescein-labeled H3 peptides as measured by fluorescence anisotropy. Curves represent the best fit to data as described in Materials and Methods. Binding assays were performed for the H3K9me3 peptide with HP1␣CD, CK2-treated HP1␣CD (phospho-HP1␣CD), HP1␤CD, and HP1␥CD and for the unmodified H3 peptide with HP1␣CD and phospho-HP1␣CD. Error bars represent the ranges for the standard deviations of the results of three independent measurements. (G) The dissociation constants (K d ) measured by fluorescence anisotropy.
phosphorylation at the N-terminal serine residues was also confirmed by MS/MS analysis (Fig. 3D and data not shown) . This analysis further revealed that S97 phosphorylation mainly contributed to the minor band shift, which is fully consistent with the fact that S97 is located within a consensus CK2 target sequence (Fig. 2C) . While elucidation of the in vivo involvement of CK2 in HP1␣ phosphorylation remains elusive, we used this in vitro phosphorylated HP1␣ for further analyses.
Unphosphorylated recombinant HP1␣ bound to H3K9me3 with a moderate affinity and bound negligibly to the unmodified H3 (Fig. 1B and 3E) . Notably, the CK2-mediated phosphorylation strongly improved the binding of HP1␣ to H3K9me3 (Fig. 3E, WTϩCK2) to a level similar to that of the rHP1␣ purified from NIH 3T3 cells (see Fig. 3E , rHP1␣ [NIH 3T3]). CK2 treatment had little or no effect on the binding affinity of the HP1␣S11-14A mutant, confirming that the Nterminal phosphorylation, but not the minor hinge phosphorylation(s), promoted the H3K9me3 binding of HP1␣. Intriguingly, the CK2-mediated phosphorylation also increased the affinity of HP1␣ for unmodified H3 (Fig. 3E, WTϩCK2) . Although the levels differed, weak binding to unmodified H3 was also observed for the HP1␣ purified from NIH 3T3 cells ( Fig.  1D and 3E ). This implied a distinct role of HP1␣'s N-terminal phosphorylation in its binding to histone H3 (see below).
To confirm the effect of the N-terminal phosphorylation, we monitored the affinity of CK2-phosphorylated HP1␣CD for the H3K9me3 peptide by fluorescence anisotropy measurements (18) (Fig. 3F) . By MS/MS analysis, we confirmed that the N-terminal phosphorylation pattern of the CK2-phosphorylated HP1␣CD was similar to that of CK2-phosphorylated full-length HP1␣ (Fig. 3D ). As seen with the results of the pulldown assays, the unphosphorylated HP1␣CD had an affinity for the H3K9me3 peptide 4 to 6 times lower than that of HP1␤CD or HP1␥CD (Fig. 3F and G) . CK2-mediated N-terminal phosphorylation increased the affinity of the HP1␣CD for the H3K9me3 peptide to a level comparable to that of the other HP1 CDs (Fig. 3F and G, Phos-HP1␣CD ). Taken together, these results indicated that the N-terminal phosphorylation of HP1␣ enhanced the binding of HP1␣ to H3K9me3. Note that the increased affinity of phosphorylated HP1␣ for unmodified H3 was also confirmed in this experiment (Fig. 3F) , although the affinity was weak, and it was difficult to obtain a reliable K d value.
The N-terminal phosphorylation and the CD make distinct contributions to HP1␣'s binding to H3K9me3. The N-terminal serine residues of HP1␣ that undergo phosphorylation are located next to a cluster of acidic amino acids (composed of amino acids E and D), and additional acidic amino acids are present in the corresponding region of HP1␤ and HP1␥ (Fig.  4A) . To test whether phosphorylated serine plays a role similar to that of the acidic amino acids, we replaced the N-terminal serine residues (S11-14) of recombinant HP1␣ with glutamic acid (E) and tested its binding affinity for H3K9me3. Although the S11-14E mutation indeed increased HP1␣'s affinity for H3K9me3 compared with the unphosphorylated HP1␣WT, HP1␣S11-14E did not perfectly mimic the phosphorylated HP1␣WT ( Fig. 4B ; compare WT ϩ CK2 and S11-14E). A clear difference was also seen in its binding to the unmodified H3 tail. These results suggested that the phosphorylated serine and acidic amino acids are functionally related but that they mutant HP1␣ species (Fig. 6C ). These observations suggested that phosphorylation of the N-terminal serine residues is required for the proper heterochromatic localization of HP1␣. Since reduced heterochromatic localization was observed for HP1␣ with the S11-13A mutation (Fig. 6C) , not only S14 phosphorylation but also neighboring phosphorylation(s) of the other N-terminal serine residues are likely to contribute to targeting of HP1␣ to heterochromatin. Although we mapped S93 as the major metaphase-specific phosphorylation site, HP1␣ with a hinge mutation (S93A or S93E) did not have a noticeable effect on HP1␣'s heterochromatic localization in our mitotic cell-excluding scoring HP1␣WT, but not mutant HP1␣S14A, stably bound to the chromatin-enriched nuclear fraction. NIH 3T3 cells expressing wild-type or mutant (S14A) HP1␣ were transfected with control siRNA or siRNA directed against HP1␣, and whole-cell lysate (W), soluble supernatant (S), and chromatin-enriched pellet (P) fractions were obtained. The proteins in each fraction were resolved by SDS-PAGE and analyzed by immunoblotting. (E) Coimmunoprecipitation of histone H3 nucleosomes with FLAG-HP1␣. Whole-cell lysates of NIH 3T3 cells stably expressing FLAG-HP1␣WT or FLAG-HP1␣S11-14A were treated with micrococcal nuclease, and FLAG-HP1␣ and associated histone H3 nucleosomes were precipitated using anti-FLAG M2 beads. The precipitated fractions were analyzed by immunoblotting using the antibodies against the histone H3 C terminus, H3K9me3, or H3K4me3. although CK2 is the most likely kinase candidate for the Nterminal phosphorylation of HP1␣, it remains possible that some other kinase(s) is responsible for it in vivo.
Phosphorylation is one of the most common mechanisms for regulating the localization and functions of HP1 family proteins. For example, HP1␥'s euchromatic localization and transcriptional activator functions coincide with the phosphorylation of its hinge region (29) . In this study, we showed that HP1␣ undergoes similar phosphorylation in its hinge region, but this phosphorylation occurs in a cell cycle-dependent manner and does not have obvious effects on HP1␣'s nuclear localization (data not shown). The role of the hinge phosphorylation, therefore, may differ depending on the HP1 isoform or homologue.
In studies of Drosophila, it has been demonstrated that an N-terminal serine (S15) of HP1a is phosphorylated by CK2 and that this phosphorylation plays a role in heterochromatin-mediated silencing (47, 48) . However, it remains unresolved how S15 contributes to HP1a's chromatin targeting function. Since S15 also lies close to the CD (Fig. 4A) , it is likely that its phosphorylation plays a similar role to promote the binding of Drosophila HP1a. Indeed, CK2 treatment increased the affinity of Drosophila HP1a for H3K9me3 in a manner similar to that observed for mouse HP1␣ (data not shown). Thus, the phosphorylation-mediated regulation of CD function appears to be conserved in evolutionarily distant species. In S. pombe, Swi6, one of the HP1 family proteins, also undergoes CK2-mediated phosphorylation in vivo (42) . In that case, however, the phosphorylation does not appear to alter the chromatin-binding activity of Swi6 but rather modulates the interaction between Swi6 and other trans-acting factors.
Our data suggest that the primary role of the N-terminal phosphorylation is the efficient targeting of HP1␣ to H3K9me-enriched heterochromatic regions. The initial targeting step appears to be critical to the HP1␣'s function in vivo. The unphosphorylatable mutant HP1␣ showed defects in heterochromatic localization (Fig. 6) , and the overexpression of this mutant caused chromosomal abnormalities as a dominant effect (Fig. 7) . It was recently reported that the expression state of HP1␣, but not of HP1␤ or HP1␥, is tightly linked with tumorigenesis (7). Although we have not yet identified a situation in which the N-terminal region of HP1␣ becomes dephosphorylated in vivo, it is possible that the deregulation of HP1␣ phosphorylation further accelerates chromosomal instability. Exploring the regulatory mechanisms of HP1␣ phosphorylation may elucidate the functional relationship between HP1 proteins and chromosome integrity.
